CTT PHARMACEUTICAL HOLDINGS, INC. purchased $175 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-10.
How this was made
The 30-second read
Why it matters
The transaction is unlikely to move the stock price or alter market perception.
Market read
Minimal relevance; the filing provides a routine disclosure with no actionable insight.
What to watch
Potential future insider activity or upcoming corporate events not disclosed.
Background
Form 4 filings disclose insider transactions; this filing reports a modest purchase by the CEO.
Ticker impact
CEO purchased 3,500 shares for $175 via open-market transaction reported in Form 4.
No material price movement expected.
The purchase size is trivial relative to total shares outstanding and unlikely to influence investor sentiment.
Market effects
None significant; insider activity does not affect the pharmaceutical sector broadly.
No regional impact anticipated.
Not relevant to global markets.
Counterpoint
Even small insider buys can signal confidence; however, the amount is too small to be meaningful.
Key entities
- CompanyCTT Pharmaceutical Holdings, Inc.
Issuer of the Form 4 filing.
- PersonCEO (unnamed)
Insider executing the purchase.